Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 17

    1.

    The Pro12Ala polymorphism of the PPARgamma2 gene is associated with hepatic glucose uptake during hyperinsulinemia in subjects with type 2 diabetes mellitus.

    Honka MJ, Vänttinen M, Iozzo P, Virtanen KA, Lautamäki R, Hällsten K, Borra RJ, Takala T, Viljanen AP, Kemppainen J, Pihlajamäki J, Knuuti J, Nuutila P, Laakso M.

    Metabolism. 2009 Apr;58(4):541-6.PMID: 19303976 [PubMed - indexed for MEDLINE]Related articles

    2.

    Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus.

    Borra R, Lautamäki R, Parkkola R, Komu M, Sijens PE, Hällsten K, Bergman J, Iozzo P, Nuutila P.

    Metabolism. 2008 Oct;57(10):1445-51.PMID: 18803951 [PubMed - indexed for MEDLINE]Related articles

    3.

    Exercise training with dietary counselling increases mitochondrial chaperone expression in middle-aged subjects with impaired glucose tolerance.

    Venojärvi M, Aunola S, Puhke R, Marniemi J, Hämäläinen H, Halonen JP, Lindström J, Rastas M, Hällsten K, Nuutila P, Hänninen O, Atalay M.

    BMC Endocr Disord. 2008 Mar 27;8:3.PMID: 18371210 [PubMed - in process]Related articlesFree article

    4.

    Exercise restores skeletal muscle glucose delivery but not insulin-mediated glucose transport and phosphorylation in obese subjects.

    Slimani L, Oikonen V, Hällsten K, Savisto N, Knuuti J, Nuutila P, Iozzo P.

    J Clin Endocrinol Metab. 2006 Sep;91(9):3394-403. Epub 2006 Jun 13.PMID: 16772346 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of rosiglitazone on early-morning plasma cortisol levels.

    Catrina SB, Virtanen K, Hällsten K, Lönnqvist F, Nuutila P, Brismar K.

    Neuro Endocrinol Lett. 2005 Dec;26(6):763-4; author reply 765.PMID: 16380670 [PubMed - indexed for MEDLINE]Related articles

    6.

    Single nucleotide polymorphisms in the peroxisome proliferator-activated receptor delta gene are associated with skeletal muscle glucose uptake.

    Vänttinen M, Nuutila P, Kuulasmaa T, Pihlajamäki J, Hällsten K, Virtanen KA, Lautamäki R, Peltoniemi P, Takala T, Viljanen AP, Knuuti J, Laakso M.

    Diabetes. 2005 Dec;54(12):3587-91.PMID: 16306381 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double-blind, randomized study with metformin.

    Viljanen AP, Virtanen KA, Järvisalo MJ, Hällsten K, Parkkola R, Rönnemaa T, Lönnqvist F, Iozzo P, Ferrannini E, Nuutila P.

    J Clin Endocrinol Metab. 2005 Dec;90(12):6523-8. Epub 2005 Sep 27.PMID: 16189256 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study.

    Virtanen KA, Iozzo P, Hällsten K, Huupponen R, Parkkola R, Janatuinen T, Lönnqvist F, Viljanen T, Rönnemaa T, Lönnroth P, Knuuti J, Ferrannini E, Nuutila P.

    Diabetes. 2005 Sep;54(9):2720-6.PMID: 16123362 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study.

    Karlsson HK, Hällsten K, Björnholm M, Tsuchida H, Chibalin AV, Virtanen KA, Heinonen OJ, Lönnqvist F, Nuutila P, Zierath JR.

    Diabetes. 2005 May;54(5):1459-67.PMID: 15855334 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The effect of the Ala12 allele of the peroxisome proliferator-activated receptor-gamma2 gene on skeletal muscle glucose uptake depends on obesity: a positron emission tomography study.

    Vänttinen M, Nuutila P, Pihlajamäki J, Hällsten K, Virtanen KA, Lautamäki R, Peltoniemi P, Kemppainen J, Takala T, Viljanen AP, Knuuti J, Laakso M.

    J Clin Endocrinol Metab. 2005 Jul;90(7):4249-54. Epub 2005 Apr 26.PMID: 15855261 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone.

    Hällsten K, Virtanen KA, Lönnqvist F, Janatuinen T, Turiceanu M, Rönnemaa T, Viikari J, Lehtimäki T, Knuuti J, Nuutila P.

    Diabet Med. 2004 Dec;21(12):1280-7.PMID: 15569129 [PubMed - indexed for MEDLINE]Related articles

    12.

    Myocardial perfusion reserve and oxidative metabolism contribute to exercise capacity in patients with dilated cardiomyopathy.

    Stolen KQ, Kemppainen J, Kalliokoski KK, Hällsten K, Luotolahti M, Karanko H, Lehikoinen P, Viljanen T, Salo T, Airaksinen KE, Nuutila P, Knuuti J.

    J Card Fail. 2004 Apr;10(2):132-40.PMID: 15101025 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes.

    Iozzo P, Hallsten K, Oikonen V, Virtanen KA, Parkkola R, Kemppainen J, Solin O, Lonnqvist F, Ferrannini E, Knuuti J, Nuutila P.

    Diabetes Care. 2003 Jul;26(7):2069-74.PMID: 12832315 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control.

    Iozzo P, Hallsten K, Oikonen V, Virtanen KA, Kemppainen J, Solin O, Ferrannini E, Knuuti J, Nuutila P.

    J Clin Endocrinol Metab. 2003 May;88(5):2055-60.PMID: 12727954 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Insulin- and exercise-stimulated skeletal muscle blood flow and glucose uptake in obese men.

    Hällsten K, Yki-Järvinen H, Peltoniemi P, Oikonen V, Takala T, Kemppainen J, Laine H, Bergman J, Bolli GB, Knuuti J, Nuutila P.

    Obes Res. 2003 Feb;11(2):257-65.PMID: 12582222 [PubMed - indexed for MEDLINE]Related articles

    16.

    Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects.

    Virtanen KA, Hällsten K, Parkkola R, Janatuinen T, Lönnqvist F, Viljanen T, Rönnemaa T, Knuuti J, Huupponen R, Lönnroth P, Nuutila P.

    Diabetes. 2003 Feb;52(2):283-90.PMID: 12540598 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes.

    Hällsten K, Virtanen KA, Lönnqvist F, Sipilä H, Oksanen A, Viljanen T, Rönnemaa T, Viikari J, Knuuti J, Nuutila P.

    Diabetes. 2002 Dec;51(12):3479-85.PMID: 12453903 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...